Literature DB >> 21824140

Decreased α4β2 nicotinic receptor number in the absence of mRNA changes suggests post-transcriptional regulation in the spontaneously hypertensive rat model of ADHD.

Mattis B Wigestrand1, Yann S Mineur, Christopher J Heath, Frode Fonnum, Marina R Picciotto, Sven Ivar Walaas.   

Abstract

The spontaneously hypertensive rat (SHR) is widely used as a model of attention-deficit/hyperactivity disorder (ADHD). Deficits in central nicotinic receptors (nAChRs) have been previously observed in SHRs, which is interesting since epidemiological studies have identified an association between smoking and ADHD symptoms in humans. Here, we examine whether nAChR deficits in SHRs compared with Wistar Kyoto rat (WKY) controls are nAChR subtype-specific and whether these deficits correlate with changes at the level of mRNA transcription in specific brain regions. Levels of binding sites (B(max) ) and dissociation constants (K(d)) for nAChRs were determined from saturation curves of high-affinity [³H]epibatidine- and [³H] Methyllycaconitine (MLA) binding to membranes from cortex, striatum, hippocampus and cerebellum. In additional brain regions, nAChRs were examined by autoradiography with [¹²⁵I]A-85380 and [¹²⁵I]α-bungarotoxin. Levels of mRNA encoding nAChR subunits were measured using quantitative real-time PCR (qPCR). We showed that the number of α4β2 nAChR binding sites is lower globally in the SHR brain compared with WKY in the absence of significant differences in mRNA levels, with the exception of lower α4 mRNA in cerebellum of SHR compared with WKY. Furthermore, nAChR deficits were subtype- specific because no strain difference was found in α7 nAChR binding or α7 mRNA levels. Our results suggest that the lower α4β2 nAChR number in SHR compared with WKY may be a consequence of dysfunctional post-transcriptional regulation of nAChRs.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21824140      PMCID: PMC3171636          DOI: 10.1111/j.1471-4159.2011.07415.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  71 in total

Review 1.  Attention-deficit/hyperactivity disorder: a plausible mouse model?

Authors:  Sylvie Granon; Jean-Pierre Changeux
Journal:  Acta Paediatr       Date:  2006-06       Impact factor: 2.299

2.  A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand.

Authors:  J P Sullivan; D Donnelly-Roberts; C A Briggs; D J Anderson; M Gopalakrishnan; M Piattoni-Kaplan; J E Campbell; D G McKenna; E Molinari; A M Hettinger; D S Garvey; J T Wasicak; M W Holladay; M Williams; S P Arneric
Journal:  Neuropharmacology       Date:  1996-06       Impact factor: 5.250

3.  Gene-environment interplay in attention-deficit hyperactivity disorder and the importance of a developmental perspective.

Authors:  Anita Thapar; Kate Langley; Philip Asherson; Michael Gill
Journal:  Br J Psychiatry       Date:  2007-01       Impact factor: 9.319

4.  Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors.

Authors:  A R Davies; D J Hardick; I S Blagbrough; B V Potter; A J Wolstenholme; S Wonnacott
Journal:  Neuropharmacology       Date:  1999-05       Impact factor: 5.250

Review 5.  Animal models of attention-deficit hyperactivity disorder.

Authors:  Eugen Davids; Kehong Zhang; Frank I Tarazi; Ross J Baldessarini
Journal:  Brain Res Brain Res Rev       Date:  2003-04

6.  Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder.

Authors:  D E Comings; R Gade-Andavolu; N Gonzalez; S Wu; D Muhleman; H Blake; F Chiu; E Wang; K Farwell; S Darakjy; R Baker; G Dietz; G Saucier; J P MacMurray
Journal:  Clin Genet       Date:  2000-07       Impact factor: 4.438

Review 7.  Attention-deficit hyperactivity disorder.

Authors:  Joseph Biederman; Stephen V Faraone
Journal:  Lancet       Date:  2005 Jul 16-22       Impact factor: 79.321

8.  Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation.

Authors:  Montserrat C Cruzado; Norma R Risler; Roberto M Miatello; Guoying Yao; Ernesto L Schiffrin; Rhian M Touyz
Journal:  Am J Hypertens       Date:  2005-01       Impact factor: 2.689

Review 9.  Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence.

Authors:  Karen Markussen Linnet; Søren Dalsgaard; Carsten Obel; Kirsten Wisborg; Tine Brink Henriksen; Alina Rodriguez; Arto Kotimaa; Irma Moilanen; Per Hove Thomsen; Jørn Olsen; Marjo-Riitta Jarvelin
Journal:  Am J Psychiatry       Date:  2003-06       Impact factor: 18.112

10.  John Daly's compound, epibatidine, facilitates identification of nicotinic receptor subtypes.

Authors:  Michael J Marks; Duncan S Laverty; Paul Whiteaker; Outi Salminen; Sharon R Grady; J Michael McIntosh; Allan C Collins
Journal:  J Mol Neurosci       Date:  2009-08-12       Impact factor: 3.444

View more
  6 in total

1.  Nicotine Addiction and Psychiatric Disorders.

Authors:  Munir Gunes Kutlu; Vinay Parikh; Thomas J Gould
Journal:  Int Rev Neurobiol       Date:  2015-09-19       Impact factor: 3.230

Review 2.  High-affinity nicotinic acetylcholine receptor expression and trafficking abnormalities in psychiatric illness.

Authors:  Alan S Lewis; Marina R Picciotto
Journal:  Psychopharmacology (Berl)       Date:  2013-04-28       Impact factor: 4.530

3.  Detrimental effects of acute nicotine on the response-withholding performance of spontaneously hypertensive and Wistar Kyoto rats.

Authors:  Gabriel J Mazur; Gabriel Wood-Isenberg; Elizabeth Watterson; Federico Sanabria
Journal:  Psychopharmacology (Berl)       Date:  2014-01-11       Impact factor: 4.530

4.  Hippocampal knockdown of α2 nicotinic or M1 muscarinic acetylcholine receptors in C57BL/6J male mice impairs cued fear conditioning.

Authors:  Yann S Mineur; Charlotte Ernstsen; Ashraful Islam; Kathrine Lefoli Maibom; Marina R Picciotto
Journal:  Genes Brain Behav       Date:  2020-07       Impact factor: 3.449

5.  Evidence of Altered Brain Responses to Nicotine in an Animal Model of Attention Deficit/Hyperactivity Disorder.

Authors:  Guillaume L Poirier; Wei Huang; Kelly Tam; Joseph R DiFranza; Jean A King
Journal:  Nicotine Tob Res       Date:  2017-09-01       Impact factor: 4.244

Review 6.  DNA methylome perturbations: an epigenetic basis for the emergingly heritable neurodevelopmental abnormalities associated with maternal smoking and maternal nicotine exposure†.

Authors:  Jordan M Buck; Li Yu; Valerie S Knopik; Jerry A Stitzel
Journal:  Biol Reprod       Date:  2021-09-14       Impact factor: 4.161

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.